ROCHLIN KATE (Chief Operating Officer) exercised options at IN8BIO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock
Shares
+12.29K
Price / share
$0.18
Trade value
$2.27K
% of position
Net shares
+12.29K
Net value
$2.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2025 | M · Option Exercise | +12.29K | $0.18 | $2.27K | 28.7% | 42.87K | 55.17K |
| Total | +12.29K | $2.27K | ||||||
Series A Warrants (right to buy)
Common Stock
12.29K shares
Shares
−12.29K
Strike price
0.45
Held after
0.00
Exercisable
—
Series A Warrants (right to buy)
Common Stock
12.29K shares
Shares
+12.29K
Strike price
0.1844
Held after
12.29K
Exercisable
—
Series B Warrants (right to buy)
Common Stock
12.29K shares
Shares
−12.29K
Strike price
1.50
Held after
0.00
Exercisable
—
Series B Warrants (right to buy)
Common Stock
12.29K shares
Shares
+12.29K
Strike price
0.45
Held after
12.29K
Exercisable
—
Series A Warrants (right to buy)
Common Stock
12.29K shares
Shares
−12.29K
Strike price
0.1844
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrants (right to buy) Direct | Common Stock12.29K shares | 4/27/2025 | D · Disposition | −12.29K | 0.45 | — | 0.00 |
| Series A Warrants (right to buy) Direct | Common Stock12.29K shares | 4/27/2025 | A · Award | +12.29K | 0.1844 | — | 12.29K |
| Series B Warrants (right to buy) Direct | Common Stock12.29K shares | 4/27/2025 | D · Disposition | −12.29K | 1.50 | — | 0.00 |
| Series B Warrants (right to buy) Direct | Common Stock12.29K shares | 4/27/2025 | A · Award | +12.29K | 0.45 | — | 12.29K |
| Series A Warrants (right to buy) Direct | Common Stock12.29K shares | 4/30/2025 | M · Option Exercise | −12.29K | 0.1844 | — | 0.00 |